Enter 2021.03.19 16:25 | Revision 2021.03.19 16:28
The Corona 19 Vaccination Response Promotion Team (Promotion Team) said on the 19th, “The Vaccination Specialized Committee will be held this weekend to review the recent evaluations of the World Health Organization (WHO) and EMA with experts and announce it on the 22nd.” Revealed.
On the 18th (local time), the EMA-affiliated Drug Surveillance and Risk Assessment Committee (PRAC) announced the evaluation results saying, “There is no causal relationship between AstraZeneca Corona 19 vaccination and blood clot symptoms.” However, EMA stated that “the relationship cannot be clearly ruled out” between certain very rare types of blood clots and vaccines, and recommended adding relevant explanations to the vaccine information so that patients and healthcare workers can know.
The EMA is responsible for the evaluation and approval of pharmaceuticals and vaccines in the European Union (EU). EMA held an extraordinary meeting on the same day, concluded on the information collected so far, and revealed the results of the investigation.
According to this announcement, Germany, France, Italy and Spain will resume AstraZeneca vaccination after the EMA announcement.
The government is also planning to proceed with vaccination according to the existing plan. Prime Minister Jeong Sye-gyun said after the evaluation result of EMA came out, “Considering the results of international organization verification and adverse reaction cases confirmed so far, we believe that there is no reason to stop the domestic AZ vaccination.” Prime Minister Chung said in an emergency directive sent to the Korea Centers for Disease Control and Prevention and the Ministry of Food and Drug Safety that day, he reaffirmed the government’s policy and ordered the quarantine authorities to quickly clear up their stance on the AZ vaccine safety controversy, the Prime Minister’s office said.